Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2020

Sep 9, 2020

30786_dirs_2020-09-09_2bd149b2-99fb-4606-ac84-e8de55066d58.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-09-04

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-04 Bio-Rad A Common Stock M 500 Acquired 1305.7969 Direct
2020-09-04 Bio-Rad A Common Stock F 173 $484.23 Disposed 1132.7969 Direct
2020-09-05 Bio-Rad A Common Stock M 500 Acquired 1632.7969 Direct
2020-09-05 Bio-Rad A Common Stock F 173 $484.23 Disposed 1459.7969 Direct
2020-09-07 Bio-Rad A Common Stock M 500 Acquired 1959.7969 Direct
2020-09-07 Bio-Rad A Common Stock F 237 $484.23 Disposed 1722.7969 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-09-07 Restricted Stock Units $0 M 500 Disposed Bio-Rad A Common Stock (500) Direct
2020-09-05 Restricted Stock Units $0 M 500 Disposed Bio-Rad A Common Stock (500) Direct
2020-09-04 Restricted Stock Units $0 M 500 Disposed Bio-Rad A Common Stock (500) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 7, 2017.

F4: The restricted stock units vest in five equal annual installments beginning September 5, 2018.

F5: The restricted stock units vest in five equal annual installments beginning September 4, 2019.